Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
Br J Surg
    September 2021
  1. BONNOT PE, Lintis A, Mercier F, Benzerdjeb N, et al
    Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study).
    Br J Surg. 2021 Sep 9. pii: 6366963. doi: 10.1093.
    >> Share

  2. PARK DJ, Kim YW, Yang HK, Ryu KW, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
    Br J Surg. 2021 Sep 6. pii: 6364812. doi: 10.1093.
    >> Share

    June 2021
  3. ALKHAFFAF B, Metryka A, Blazeby JM, Glenny AM, et al
    Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient and healthcare professional consensus.
    Br J Surg. 2021 Jun 24. pii: 6308782. doi: 10.1093.
    >> Share

    May 2021
  4. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2021;108:542-549.
    >> Share

    March 2021
  5. KOEMANS WJ, van der Kaaij RT, van Sandick JW
    Reply to Correspondence to "Treatment of PERItoneal dissemination in Stomach Cancer patients with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy (HIPEC): first results of the PERISCOPE I study".
    Br J Surg. 2021;108:e94.
    >> Share

  6. CHIU CC, Lee PH, Chang CS, Rau KM, et al
    Correspondence to 'Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results'.
    Br J Surg. 2021;108:e93.
    >> Share

    January 2021
  7. KAMARAJAH SK, Navidi M, Phillips AW
    Response to "Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer".
    Br J Surg. 2021 Jan 31. pii: 6124825. doi: 10.1093.
    >> Share

  8. HU Q, Sun Y, Yang X
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2021 Jan 31. pii: 6124822. doi: 10.1093.
    >> Share

    November 2020
  9. LIU Y, Yang T, Wei YW
    What is the difference between overall survival, recurrence-free survival and time-to-recurrence?
    Br J Surg. 2020;107:e634.
    >> Share

    October 2020
  10. HUANG J, Yang B, Tan J, Zhou S, et al
    Gastric cancer nodal tumour-stroma ratios influence prognosis.
    Br J Surg. 2020 Oct 14. doi: 10.1002/bjs.12054.
    >> Share

  11. JESTIN HANNAN C, Linder G, Kung CH, Johansson J, et al
    Geographical differences in cancer treatment and survival for patients with oesophageal and gastro-oesophageal junctional cancers.
    Br J Surg. 2020;107:1500-1509.
    >> Share

  12. VAN DER KAAIJ RT, Wassenaar ECE, Koemans WJ, Sikorska K, et al
    Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results.
    Br J Surg. 2020;107:1520-1528.
    >> Share

    September 2020
  13. JIN C, Jiang Y, Yu H, Wang W, et al
    Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11928.
    >> Share

  14. KAMARAJAH SK, Phillips AW
    Author response: Anastomotic leak does impact on long-term survival in gastric cancer patients.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11944.
    >> Share

  15. KAMARAJAH SK, Phillips AW
    Author response to: Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11953.
    >> Share

  16. DIAO YK, Jia HD, Huang DS, Zhang CW, et al
    Comment on: Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Sep 21. doi: 10.1002/bjs.11954.
    >> Share

    August 2020
  17. LIN JP, Zhao YJ, He QL, Hao HK, et al
    Adjuvant chemotherapy for patients with gastric neuroendocrine carcinomas or mixed adenoneuroendocrine carcinomas.
    Br J Surg. 2020;107:1163-1170.
    >> Share

    June 2020
  18. KAMARAJAH SK, Navidi M, Griffin SM, Phillips AW, et al
    Impact of anastomotic leak on long-term survival in patients undergoing gastrectomy for gastric cancer.
    Br J Surg. 2020 Jun 13. doi: 10.1002/bjs.11749.
    >> Share

  19. AN JY, Min JS, Hur H, Lee YJ, et al
    Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA).
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11655.
    >> Share

    May 2020
  20. RI M, Nunobe S, Honda M, Akimoto E, et al
    Gastrectomy with or without omentectomy for cT3-4 gastric cancer: a multicentre cohort study.
    Br J Surg. 2020 May 20. doi: 10.1002/bjs.11702.
    >> Share

    February 2020
  21. ROH CK, Choi S, Seo WJ, Cho M, et al
    Indocyanine green fluorescence lymphography during gastrectomy after initial endoscopic submucosal dissection for early gastric cancer.
    Br J Surg. 2020 Feb 7. doi: 10.1002/bjs.11438.
    >> Share

  22. LU J, Zhao YJ, Zhou Y, He Q, et al
    Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
    Br J Surg. 2020;107:248-257.
    >> Share

    January 2020

  23. Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2020;107:120.
    >> Share

  24. SAUNDERS JH, Yanni F, Dorrington MS, Bowman CR, et al
    Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
    Br J Surg. 2020;107:103-112.
    >> Share

    November 2019
  25. DATTA J, Da Silva EM, Kandoth C, Song T, et al
    Poor survival after resection of early gastric cancer: extremes of survivorship analysis reveal distinct genomic profile.
    Br J Surg. 2019 Nov 25. doi: 10.1002/bjs.11443.
    >> Share

    October 2019
  26. MISAWA K, Mochizuki Y, Sakai M, Teramoto H, et al
    Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial).
    Br J Surg. 2019 Oct 1. doi: 10.1002/bjs.11303.
    >> Share

    September 2019
  27. ZHAO Z, Wang Y
    Comment on: Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Br J Surg. 2019;106:1416.
    >> Share

    August 2019
  28. ALLUM WH, Smyth EC, Blazeby JM, Grabsch HI, et al
    Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro-oesophageal junction.
    Br J Surg. 2019;106:1204-1215.
    >> Share

  29. LIN JX, Yoon C, Desiderio J, Yi BC, et al
    Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
    Br J Surg. 2019;106:1187-1196.
    >> Share

    July 2019
  30. BROZA YY, Khatib S, Gharra A, Krilaviciute A, et al
    Screening for gastric cancer using exhaled breath samples.
    Br J Surg. 2019 Jul 1. doi: 10.1002/bjs.11294.
    >> Share

    June 2019
  31. CHEN AH, Chan WH, Lee YH, Tseng JH, et al
    Routine chest CT for staging of gastric cancer.
    Br J Surg. 2019 Jun 18. doi: 10.1002/bjs.11186.
    >> Share


  32. Snapshot quiz.
    Br J Surg. 2019;106:878.
    >> Share

    August 2018
  33. VAN PUTTEN M, Nelen SD, Lemmens VEPP, Stoot JHMB, et al
    Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
    Br J Surg. 2018 Aug 22. doi: 10.1002/bjs.10931.
    >> Share

    June 2018
  34. NAVIDI M, Phillips AW, Griffin SM, Duffield KE, et al
    Cardiopulmonary fitness before and after neoadjuvant chemotherapy in patients with oesophagogastric cancer.
    Br J Surg. 2018;105:900-906.
    >> Share

    May 2018
  35. KANDA M, Shimizu D, Tanaka H, Tanaka C, et al
    Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer.
    Br J Surg. 2018 May 9. doi: 10.1002/bjs.10876.
    >> Share

  36. CLAASSEN YHM, van Sandick JW, Hartgrink HH, Dikken JL, et al
    Association between hospital volume and quality of gastric cancer surgery in the CRITICS trial.
    Br J Surg. 2018;105:728-735.
    >> Share

    April 2018
  37. ZENG D, Zhou R, Yu Y, Luo Y, et al
    Gene expression profiles for a prognostic immunoscore in gastric cancer.
    Br J Surg. 2018 Apr 25. doi: 10.1002/bjs.10871.
    >> Share

  38. NELEN SD, Bosscha K, Lemmens VEPP, Hartgrink HH, et al
    Morbidity and mortality according to age following gastrectomy for gastric cancer.
    Br J Surg. 2018 Apr 23. doi: 10.1002/bjs.10836.
    >> Share

  39. VAN DER KAAIJ RT, de Rooij MV, van Coevorden F, Voncken FEM, et al
    Using textbook outcome as a measure of quality of care in oesophagogastric cancer surgery.
    Br J Surg. 2018;105:561-569.
    >> Share

    January 2018
  40. MARKAR SR, Mackenzie H, Wiggins T, Askari A, et al
    Influence of national centralization of oesophagogastric cancer on management and clinical outcome from emergency upper gastrointestinal conditions.
    Br J Surg. 2018;105:113-120.
    >> Share

  41. POWELL AGMT, Soul S, Christian A, Lewis WG, et al
    Meta-analysis of the prognostic value of CpG island methylator phenotype in gastric cancer.
    Br J Surg. 2018;105:e61-e68.
    >> Share

  42. VAN DER KAAIJ RT, van Kessel JP, van Dieren JM, Snaebjornsson P, et al
    Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    Br J Surg. 2018;105:e176-e182.
    >> Share

    December 2017
  43. NOBLE F, Lloyd MA, Turkington R, Griffiths E, et al
    Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
    Br J Surg. 2017;104:1816-1828.
    >> Share

  44. KAWAKATSU S, Ohashi M, Hiki N, Nunobe S, et al
    Use of endoscopy to determine the resection margin during laparoscopic gastrectomy for cancer.
    Br J Surg. 2017;104:1829-1836.
    >> Share

    November 2017
  45. POLOM K, Marano L, Marrelli D, De Luca R, et al
    Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer.
    Br J Surg. 2017 Nov 1. doi: 10.1002/bjs.10663.
    >> Share

    October 2017
  46. DENG J, Guo J, Ma G, Zhang H, et al
    Prognostic value of the cancer oncogene Kelch-like 6 in gastric cancer.
    Br J Surg. 2017 Oct 17. doi: 10.1002/bjs.10628.
    >> Share

    September 2017
  47. KJAER DW, Larsson H, Svendsen LB, Jensen LS, et al
    Changes in treatment and outcome of oesophageal cancer in Denmark between 2004 and 2013.
    Br J Surg. 2017;104:1338-1345.
    >> Share

    August 2017
  48. NELEN SD, van Putten M, Lemmens VEPP, Bosscha K, et al
    Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancer.
    Br J Surg. 2017 Aug 9. doi: 10.1002/bjs.10621.
    >> Share

  49. WANG ZX, Li GX, Zhou ZW, Huang ZP, et al
    Validation of a nomogram for selecting patients for chemotherapy after D2 gastrectomy for cancer.
    Br J Surg. 2017;104:1226-1234.
    >> Share

    May 2017
  50. LIN C, Liu H, Zhang H, Cao Y, et al
    Tryptase expression as a prognostic marker in patients with resected gastric cancer.
    Br J Surg. 2017 May 24. doi: 10.1002/bjs.10546.
    >> Share

  51. BENCIVENGA M, Verlato G, Han DS, Marrelli D, et al
    Validation of two prognostic models for recurrence and survival after radical gastrectomy for gastric cancer.
    Br J Surg. 2017 May 10. doi: 10.1002/bjs.10551.
    >> Share

  52. BUSWEILER LA, Schouwenburg MG, van Berge Henegouwen MI, Kolfschoten NE, et al
    Textbook outcome as a composite measure in oesophagogastric cancer surgery.
    Br J Surg. 2017;104:742-750.
    >> Share

    February 2017
  53. CHANG JS, Kim KH, Yoon HI, Hyung WJ, et al
    Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.
    Br J Surg. 2017 Feb 28. doi: 10.1002/bjs.10502.
    >> Share

  54. TOKUNAGA M, Ito S, Yoshikawa T, Nunobe S, et al
    Prognostic factors for survival in patients with pT1 N+ or T2-3 N0 gastric cancer in Japan.
    Br J Surg. 2017 Feb 27. doi: 10.1002/bjs.10509.
    >> Share

    January 2017
  55. IDA S, Hiki N, Cho H, Sakamaki K, et al
    Randomized clinical trial comparing standard diet with perioperative oral immunonutrition in total gastrectomy for gastric cancer.
    Br J Surg. 2017 Jan 10. doi: 10.1002/bjs.10417.
    >> Share

  56. TAKAGANE A, Mohri Y, Konishi T, Fukushima R, et al
    Randomized clinical trial of 24 versus 72 h antimicrobial prophylaxis in patients undergoing open total gastrectomy for gastric cancer.
    Br J Surg. 2017;104:e158-e164.
    >> Share

    December 2016
  57. YANG HK
    Gastric cancer from operating theatre to bench in Korea.
    Br J Surg. 2016;103:e193.
    >> Share

  58. BUSWEILER LA, Wijnhoven BP, van Berge Henegouwen MI, Henneman D, et al
    Early outcomes from the Dutch Upper Gastrointestinal Cancer Audit.
    Br J Surg. 2016;103:1855-1863.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016